US Drug Recall Register

FDA Drug Recalls

17,898 recalls, newest first

Class II · Moderate risk Terminated

Erythromycin Tablets

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0424-2021
Class II · Moderate risk Terminated

Vraylar

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0420-2021
Class II · Moderate risk Terminated

Rectiv

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. NDC 58914-301-80 D-0419-2021
Class II · Moderate risk Terminated

Namzaric

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. NDC 0456-1214-30 D-0418-2021
Class II · Moderate risk Terminated

Linzess

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. NDC 0456-1203-30 D-0417-2021
Class II · Moderate risk Terminated

Restasis 0.05%30x 0.4ml Opth Pf

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0416-2021
Class II · Moderate risk Terminated

Ubrelvy 100mg 10ud Cplt

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0415-2021
Class II · Moderate risk Terminated

Vaniqa

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. NDC 0023-4857-45 D-0414-2021
Class II · Moderate risk Terminated

Cosopt

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0411-2021
Class II · Moderate risk Terminated

Atropine Sulfate Ophthalmic Solution

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. NDC 17478-215-05 D-0410-2021
Class II · Moderate risk Terminated

Lidocaine HCL Visc 2% 100ml

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0409-2021
Class II · Moderate risk Terminated

Ofloxacin 0.3% 5ml Opth

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0408-2021
Class II · Moderate risk Terminated

Fenofibrate Capsules

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0407-2021
Class II · Moderate risk Terminated

Methocarbamol 500mg 500

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0406-2021
Class II · Moderate risk Terminated

Synthroid

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0405-2021
Class II · Moderate risk Terminated

Creon

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. NDC 0032-3016-13 D-0402-2021
Class II · Moderate risk Terminated

Niacin 250mg 110

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0401-2021
Class II · Moderate risk Terminated

Therapeutic M 130

Reason CGMP Deviations: Intermittent exposure to temperature excursion during storage.

Cardinal Health Inc. D-0400-2021